Final Phase I Substudy Results of Ivosidenib in Patients with Mutant IDH1 Relapsed/refractory Myelodysplastic Syndrome
Blood Advances(2024)
Key words
ivosidenib,mutant isocitrate dehydrogenase 1,2-hydroxyglutarate,first-in-human,relapsed/refractory myelodysplastic syndromes
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined